IFP Advisors’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
AWM
JIC
AWM
SS
EWA
TWC
SIC
MG
SWA
HPC
IFP Advisors's FLNA Position: Q2 2026 in Review
IFP Advisors held its Filana Therapeutics (FLNA) position steady in Q2 2026 at 10 shares worth $12. The position accounts for ﹤0.01% of the portfolio, ranked #5088.
IFP Advisors first reported a position in FLNA in Q1 2021 and has held it in 22 quarters since. The position peaked at $17K in Q2 2021. 15 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.
- IFP Advisors held 10 shares of Filana Therapeutics worth $12 as of Q2 2026.
- IFP Advisors left its Filana Therapeutics share count unchanged in Q2 2026.
- Filana Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #5088 holding.
- IFP Advisors first reported a position in Filana Therapeutics in Q1 2021 and has held it in 22 quarters since.
- IFP Advisors's Filana Therapeutics position peaked at $17K in Q2 2021.
- 15 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.